ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1265

Genetic and Epigenetic Mapping of Very Early RA Synovial Fibroblasts

Emmanuel Karouzakis1, Andrew Filer2, Stephen Eyre3, Karim Raza4, Christoph Kolling5, Renate E. Gay1, Beat A. Michel1, Jane Worthington3, Christopher Buckley6, Steffen Gay1, Michel Neidhart1 and Caroline Ospelt1, 1University Hospital Zurich, Center of Experimental Rheumatology, Switzerland, Zurich, Switzerland, 2University of Birmingham, Birmingham, United Kingdom, 3University of Manchester,Institute of Inflammation and Repair, United Kingdom, Manchester, United Kingdom, 4University of Birmingham, Rheumatology Research Group, Institute of Inflammation and Ageing, United Kingdom, Birmingham, United Kingdom, 5Upper Extremity Dept., Schulthess Clinic Zurich, Zurich, Switzerland, 6University of Birmingham, Rheumatology Research Group, Birmingham, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: epigenetics and synovial cells, Genetic Biomarkers, synovial fluid, WNT Signaling

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Genetics, Genomics and Proteomics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Genome wide association studies (GWAS) studies from rheumatoid arthritis patients have identified SNPs, which are associated with changes in gene expression levels. Recent studies revealed epigenetic changes in DNA methylation associated with rheumatoid arthritis synovial fibroblasts (RASF). Now, we want to identify genetic variations in RASF that are associated with quantitative changes in DNA methylation at very early disease state of RA.

Methods:

SF were obtained from patients with undifferentiated arthritis (symptom duration <3 months). Patients were classified as resolving arthritis or very early RA (VeRA) depending on whether they fulfilled the ACR criteria for classification within the subsequent 18 months.  Methylation immunoprecipitation (MeDIP) and high throughput sequencing was used for the analysis of differentially methylated regions (DMRs) between resolving and very early RA (n=2). The DMRs were visualized with Integrative genome viewer (IGV) and biological pathway analysis was performed by DAVID bioinformatics tools. Rheumatoid arthritis single nucleotide polymorphisms (SNPs) associated with CpG sites were mapped together with the DMRs sequencing data.

Results:

The high throughput methylome sequencing of samples from VeRA versus resolving arthritis revealed >1000 DMRs that are associated with nearby gene promoters or introns. The gene ontology analysis of the DMRs showed significant enrichment of extracellular matrix, cell adhesion and joint development pathways. Genomic loci of WNT6, WNT8A and WNT1 secreted proteins were found to be altered by DNA methylation in very early RA disease. Next, we mapped genotypic data from RA associated CpGs  SNPs  with the DMRs sequences of very early RASF. Thereby, we found that the region containing the IL6R introning SNPs rs4576655 and rs4537645 were hypomethylated in VeRASF versus resolving arthritis SF.

Conclusion:

In this study, we clearly show that changes in DNA methylation in RASF occur even before diagnosis and differ between RA and resolving arthritis. The overlap of DMR with RA risk SNPs suggests that genetic/epigenetic interactions play a role in disease development.


Disclosure: E. Karouzakis, None; A. Filer, None; S. Eyre, None; K. Raza, None; C. Kolling, None; R. E. Gay, None; B. A. Michel, None; J. Worthington, None; C. Buckley, None; S. Gay, None; M. Neidhart, None; C. Ospelt, None.

To cite this abstract in AMA style:

Karouzakis E, Filer A, Eyre S, Raza K, Kolling C, Gay RE, Michel BA, Worthington J, Buckley C, Gay S, Neidhart M, Ospelt C. Genetic and Epigenetic Mapping of Very Early RA Synovial Fibroblasts [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/genetic-and-epigenetic-mapping-of-very-early-ra-synovial-fibroblasts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-and-epigenetic-mapping-of-very-early-ra-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology